Molecular Pathology

The University of Florida Health Pathology Laboratories’ Molecular Diagnostic Laboratory is a CLIA-certified clinical diagnostic facility responsible for the development and performance of molecular diagnostic tests for nucleic acid targets found in a variety of settings in medicine.

Services & Tests

2019 Novel Coronavirus (COVID-19), NAA
FLT3 Gene Mutation Analysis
GatorSeq (NGS Panel)
CYP2D6 Genotype (Cytochrome p450 2D6) for Drug Metabolism
CYP2C19 Genotype (Cytochrome p450 2C19) for Drug Metabolism
Thiopurine Methyltransferase (TPMT) Genotype for Drug Metabolism
Hepatitis C Virus (HCV) Genotype
B-Cell Clonality Analysis (IgH Gene Rearrangements)
T-Cell Clonality (T-Cell Receptor Gamma (TCRG)) Gene Rearrangments
Microsatellite Instability: NPCC/Lynch Syndrome
GatorPGX Panel
Hepatitis B Virus (HBV) Real-Time Polymerase Chain Reaction (PCR), Quantitative/
Hepatitis C Virus (HCV) RNA, Polymerase Chain Reaction (PCR), Quantitative
Human Papillomavirus (HPV) Detection, High Risk with Genotyping
Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
BRAF Mutation Detection
KRAS Mutation Detection
Epidermal Growth Factor Receptor Mutation Analysis (EGFR Mutation)
Factor V Leiden Mutation
Methylene Tetrahydrofolate Reductase (MTHFR) Polymorphism
Prothrombin G20210A Mutation (Factor 2 Mutation)